Scarica l'app Stockscreener
1.74
1.69%
-0.03
Dopo l'orario di chiusura:
1.69
-0.05
-2.87%
Precedente Chiudi:
$1.77
Aprire:
$1.7512
Volume 24 ore:
39,665
Relative Volume:
0.12
Capitalizzazione di mercato:
$12.77M
Reddito:
-
Utile/perdita netta:
$-7.72M
Rapporto P/E:
-0.6592
EPS:
-2.6394
Flusso di cassa netto:
$-6.25M
1 W Prestazione:
-1.14%
1M Prestazione:
-2.79%
6M Prestazione:
-11.00%
1 anno Prestazione:
-3.33%
Intervallo 1D:
$1.7086
$1.77
Intervallo di 1 settimana:
$1.7086
$1.82
Portata 52W:
$1.55
$4.4899
Edesa Biotech Inc Stock (EDSA) Company Profile
Nome
Edesa Biotech Inc
Settore
Industria
Telefono
(905) 475-1234
Indirizzo
100 SPY COURT, MARKHAM, ON
Confronta EDSA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EDSA
Edesa Biotech Inc
|
1.74 | 12.99M | 0 | -7.72M | -6.25M | -2.6394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Edesa Biotech Inc Borsa (EDSA) Ultime notizie
Edesa Biotech increases at-the-market offering limit to $2.26 million - Investing.com
Edesa Biotech Advances Dermatology and Respiratory Programs in Fiscal 2025 - TipRanks
Edesa Biotech, Inc. SEC 10-K Report - TradingView
Edesa Biotech Reports Fiscal Year 2025 Results - The Manila Times
How buybacks impact Edesa Biotech Inc. stock valueWeekly Stock Recap & Real-Time Volume Surge Alerts - Newser
Edesa Biotech (EDSA) to Release Earnings on Friday - Defense World
Will Edesa Biotech Inc. stock deliver consistent dividendsBond Market & Weekly High Potential Stock Alerts - Newser
Edesa Biotech Inc. (EDSA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Edesa Biotech Inc. stock deliver better than expected guidanceJuly 2025 Chart Watch & Daily Profit Maximizing Trade Tips - newser.com
What technical signals suggest for Edesa Biotech Inc. stock2025 Earnings Impact & Safe Capital Allocation Plans - newser.com
Will Edesa Biotech Inc. stock continue upward momentumJuly 2025 Review & Fast Gaining Stock Reports - newser.com
Edesa Biotech, Inc.Common Shares (NQ: EDSA - Markets Financial Content
Is Edesa Biotech Inc. stock affected by interest rate hikesJuly 2025 Gainers & Free Growth Oriented Trading Recommendations - newser.com
Best data tools to analyze Edesa Biotech Inc. stock2025 Fundamental Recap & Safe Swing Trade Setup Alerts - newser.com
Can Edesa Biotech Inc. stock sustain market leadership2025 Momentum Check & Risk Adjusted Swing Trade Ideas - newser.com
Will Edesa Biotech Inc. stock benefit from sector rotationMarket Rally & Scalable Portfolio Growth Methods - newser.com
Edesa Biotech, Inc. (EDSA) Presents at LSX Investival Showcase Europe 2025Slideshow - Seeking Alpha
Is ESAF Small Finance Bank a Hybrid Growth Value Stock Worth HoldingResistance Zone Identification & Free Stay Informed With Forecasts - earlytimes.in
Is Edesa Biotech Inc a good long term investmentVolatility Adjusted Trading & Free Robust Financial Gains - earlytimes.in
Has Edesa Biotech Inc. found a price floorEarnings Overview Summary & Weekly Breakout Stock Alerts - newser.com
Will Edesa Biotech Inc. stock benefit from green energy trends2025 Short Interest & Safe Capital Growth Tips - Fundação Cultural do Pará
Edesa Biotech Inc Stock Analysis and ForecastEarnings Growth Projections & Investment Risk Management Tips - earlytimes.in
[Form 4] Edesa Biotech, Inc. Insider Trading Activity - Stock Titan
HC Wainwright Raises Earnings Estimates for Edesa Biotech - Defense World
Edesa Biotech Inc Azioni (EDSA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.08%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):